Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III.

European journal of cancer (Oxford, England : 1990) - 1 Nov 2022

Wang Yang, Lian Bin, Si Lu, Mao LiLi, Chi ZhiHong, Sheng XiNan, Kong Yan, Wang Xuan, Bai Xue, Yan XieQiao, Li SiMing, Tang BiXia, Dai Jie, Zhou Li, Wei Xiaoting, Cui ChuanLiang, Guo Jun

Abstract excerpt

PURPOSE: Few studies focused on the incidence of brain metastasis in patients with acral and mucosal melanoma, and a better understanding of the incidences and predictors of brain metastasis is needed in these patients. METHOD: A prospectively accrued cohort of 799 patients with acral and mucosal melanoma in stages I-III from July 2011 to December 2015 at Peking University Cancer Hospital were included in this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Risk Factors

Share to Skin Neoplasms

Share to Testicular Neoplasms

Source

Identifiers

PMID: 36137395
DOI: 10.1016/j.ejca.2022.08.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-III.PMID 36137395Read ↗

Unraveling the Enigma of Melanoma Brain Metastasis: New Horizons in Mechanisms, Diagnosis, and TherapySemantic proximity Read ↗

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.Semantic proximity Read ↗

Melanoma Brain Metastasis, Prognostic Factors, and Survival Outcomes After First Metastatic Line Therapy: A Monocentric Retrospective Study.Semantic proximity Read ↗

Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy.Semantic proximity Read ↗

BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.Semantic proximity Read ↗

Risk Factors of Metachronous Brain Metastasis in Patients with EGFR-Mutated Advanced Non-Small Cell Lung CancerSemantic proximity Read ↗

Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant MelanomaSemantic proximity Read ↗

Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.Semantic proximity Read ↗

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.Semantic proximity Read ↗

Metastatic melanoma: a regional review and future directions.Semantic proximity Read ↗

Increased Risk of Brain Metastases Among Patients with Melanoma and PROM2 Expression in Metastatic Lymph NodesSemantic proximity Read ↗

Impact of BRAF inhibitors on surgical outcomes in melanoma brain metastases: Evidence from a multicenter observational study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.